ARIAD announces results of preclinical studies on brigatinib at AACR 2015
22 April 2015 | By Victoria White
ARIAD has announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), at AACR 2015...